Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0038187 (starvation)
 24,951 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

To study the effect of starvation on hypothalamic beta-endorphin and somatostatin (SRIF) concentrations in relation to starvation induced anestrus, groups of 8 rats were fed 50% of their normal daily chow consumption. Rats were sacrificed after 4, 8, 12, and 16 days during diestrus or anestrus. beta-endorphin concentrations decreased in the preoptic suprachiasmatic area (0.52 +/- 0.13 vs 0.21 +/- 0.05 ng/mg tissue wet weight) and increased in the posterior hypothalamus (0.31 +/- 0.06 vs 0.57 +/- 0.11 ng/mg) after 4 days of starvation. No significant change occurred in the arcuate nucleus or in the median eminence. On day 8 and 12 of starvation, beta-endorphin was unaltered in all areas compared to controls. Vaginal smears showed constant diestrus in a significant number of rats (5 out of 8) after 12 days. beta-endorphin concentrations in the arcuate nuclei of these rats were significantly reduced on day 16 (1.00 +/- 0.33 vs 0.30 +/- 0.11 ng/mg). The SRIF levels changed only in the median eminence with increased concentrations on day 12 (45.2 +/- 8.4 vs 79.5 +/- 14.8 ng/mg). At this time serum levels of luteinizing hormone (LH), prolactin (PRL), and growth hormone (GH) were significantly reduced. The results indicate that changes in hypothalamic beta-endorphin accompany the events leading to starvation induced anestrus.
 ...
PMID:Changes of beta-endorphin and somatostatin concentrations in different hypothalamic areas of female rats after chronic starvation. 613 89

A specific and sensitive homologous radioimmunoassay (RIA) for determination of golden hamster growth hormone (GH) is described and compared to a heterologous hamster GH RIA. Using the homologous system, cross-reactivity experiments between golden hamster GH on one hand, and pituitary extracts from two other hamster species, and purified GHs from several rodent and mammalian species, suggested that hamster GH differs from other rodent and mammalian GHs to a greater extent than rat GH. Using the homologous method, we have determined that, in the golden hamster, diurnal plasma fluctuations have a mean interpeak interval of 70-80 min, that serum GH concentrations are affected by nyctohemeral differences in lighting, by ether vapors, by animal's gender, and by starvation and refeeding. Basal GH concentrations were not influenced by exposure to different photoperiods or by removal of the gonads. A heterologous hamster GH RIA, which utilizes a radioiodinated rat GH and monkey antihamster GH serum, represents the most advantageous method for the measurement of hamster GH because of its high sensitivity (0.3 ng/ml), low limit of detection (46 pg/ml), high antiserum binding to iodinated rat GH, and the ability to measure rat and mouse GHs in addition to hamster GH. Immunological differences between hamster, rodent, and other mammalian GHs are diminished when heterologous, rather than homologous, tracer is used.
 ...
PMID:Hamster growth hormone. Species specificity and physiological changes in blood and pituitary concentrations as measured by a homologous radioimmunoassay. 618 12

It is well established that glucagon plays an important role in the regulation of fuel supplies as its plasma level increases during the first days of a complete fast. However, it is not certain that glucagon is involved in the adaptation to chronic starvation. In the present study, this problem was investigated by the determination of the changes in the plasma glucagon level elicited by an i.v. glucose tolerance test followed by an i.v. arginine perfusion in 26 self starved patients suffering from anorexia nervosa (AN) and 14 control patients having only minor neurotic disorders. The basal plasma glucagon level tended to be higher in the AN patients than in the controls; but the difference was not statistically significant. Glucagon responses to glucose and arginine observed in the AN patients were not significantly different from those seen in the control patients. In the AN patients, the insulin response to both loads was reduced and the plasma GH level increased paradoxically after the glucose load, whereas it rose normally after the arginine load. It may be concluded that in chronic starvation by AN the regulation of fuel supplies depends mainly on decreased insulin and increased growth hormone secretion. The role of glucagon seems to be of minor importance in this condition.
 ...
PMID:The role of insulin, glucagon and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa. 638 41

Insulin resistance is found in physiological (starvation, gestation) or pathological (diabetes, obesity, uremia, cortisol or growth hormone excess) situations. In order to study insulin resistance, a number of tests have been developed which have evolved in term of practical and conceptual complexity. In the present paper, these tests are analyzed for their reliability in answering the following questions: does an insulin resistance exist? Is it possible quantify it? What are the causes (receptor or post receptor defect) and the tissues producing or utilizing glucose involved in insulin resistance? Emphasis is placed upon a newly developed technique: the euglycemic, hyperinsulinemic glucose clamp. Progress in the knowledge of insulin resistance as well as the problems or limitations linked to this latter technique are discussed.
 ...
PMID:[Technics for studying insulin resistance in vivo]. 639 95

The effects of dopamine blockade on the endocrine and metabolic response to starvation have been investigated by administration of metoclopramide, 30 mg daily, or placebo to five normal subjects fasted for sixty hours on two occasions. Blood glucose and alanine concentrations fell with starvation and metoclopramide had no further effect. Concentrations of the other gluconeogenic precursors, lactate and pyruvate, were also unaffected by metoclopramide. The rise in circulating ketone body concentrations with fasting was impaired by metoclopramide, significantly from 44 h onwards (blood total ketone body concentration at 60 h, 3.42 +/- 0.94 mmol/l with placebo; 2.08 +/- 0.67 mmol/l with metoclopramide, P less than 0.05). Blood glycerol and plasma non-esterified fatty acids (NEFA) levels rose with starvation, and metoclopramide had no further effect. Serum insulin concentrations remained low with fasting, while circulating glucagon and growth hormone levels rose. Similar changes were noted with both metoclopramide and placebo. Serum prolactin concentrations during starvation were elevated two to four fold by metoclopramide. The inhibitory effect of dopamine blockade on ketosis thus occurred despite hyperprolactinaemia, and did not result from measurable alterations in insulin, glucagon or growth hormone secretion. The data suggest a stimulatory role for endogenous dopamine on starvation ketonaemia in man.
 ...
PMID:Dopamine blockade inhibits starvation ketosis in man. 662 95

The present experiments were undertaken to study the effect of complete food removal on body weight, pituitary growth hormone (GH), plasma GH and glucose concentration in male and female Wistar rats. Plasma and pituitary GH levels were measured by means of a specific radioimmunoassay. Plasma glucose concentration decrease during the initial 60 h fasting in males and 72 h in females, and remained fairly constant thereafter in both groups. Pituitary GH content was unchanged in males and females by 36 h and 60 h, respectively, after the onset of starvation. Thereafter, pituitary GH decreased progressively with increase of the starvation period. In spite of the changes in pituitary GH, plasma GH concentration in fasted male and female rats was similar to or higher than in controls. In fact, during an initial period, up to 72 h in males and 96 h in females, plasma GH levels in fasting rats were similar to control values. With longer starvation periods, plasma GH concentration rose above control values. After 24 h of refeeding 102 h fasted rats, plasma GH concentrations were comparable to control levels. In addition, after an initial loss of 10 g after 24 h fasting, body weight of both male and female animals decreased, and by the end of the starvation period it was about 50% of control weight. From these results it seems that complete food removal has a direct effect on pituitary GH. Furthermore, the fact that changes in plasma GH concentrations were evidentiated just before the period when plasma glucose was maintained at constant levels in fasted rats of both sexes supports the hypothesis that growth hormone plays a physiological role in the regulation of glucose homeostasis during starvation.
 ...
PMID:Effects of starvation on pituitary and plasma growth hormone in rats. 724 Jun 70

The role of dopamine in starvation ketonaemia was investigated in male Wistar rats by administration of a specific dopamine receptor antagonist, metoclopramide (4 mg . kg-1 . 24h-1), or placebo, intragastrically during a 48-h fast. Starvation alone caused a fall in blood glucose and gluconeogenic precursor concentrations, which was unaffected by metoclopramide administration. Circulating 3-hydroxybutyrate and acetoacetate levels rose with fasting alone but metoclopramide impaired this ketonaemic response. After 48-h starvation, total ketone body concentrations (mean +/- SEM) were 2.28 +/- 0.19 mmol/l with metoclopramide therapy, 3.49 +/- 0.21 mmol/l with placebo, P less than 0.001. Plasma non-esterified fatty acid levels were similar in metoclopramide- and placebo-treated animals, as were circulating concentrations of insulin, glucagon and growth hormone. Metoclopramide thus decreased the ketonaemic response to starvation without an apparent change in lipolysis or circulating hormone levels, suggesting a direct role for dopamine in production of starvation ketonaemia.
 ...
PMID:Dopaminergic control of ketogenesis in fasting. 730 78

This study describes the development of an oncorhynchid growth hormone (GH) radioimmunoassay using recombinant chum salmon GH (rsGH) and a rabbit antiserum (TJK-1) raised against this recombinant material. The assay was designed to measure the wide range of circulating immunoreactive GH (IRGH) levels in Pacific salmonids, resulting in a standard curve capable of accurately determining plasma levels of IRGH from 0.5 to 250 ng/mL without dilution. The assay ED50 and ED90 values averaged 13.1 and 0.5 ng/mL, respectively. This radioimmunoassay specifically recognizes oncorhynchid IRGH, showing no cross-reactivity with recombinant porcine and bovine GH, or natural chum salmon prolactin at concentrations up to 10 micrograms/mL. Curves approximately parallel to the standard curve were obtained with purified natural coho salmon GH and plasma from chinook salmon. Recovery of rsGH from plasma was complete over the full range of the standard curve. Intra- and inter-assay coefficients of variation were 6.0 and 12.9%, respectively. Plasma IRGH levels in fed coho salmon were 30.6 +/- 5.3 ng/mL, while those in fish starved for 2 weeks were 132.9 +/- 53.9 ng/mL. Starvation for an additional 4 weeks had no significant effect. Plasma IRGH levels in control rainbow trout injected with saline were significantly higher 45 min post-injection. In contrast, fish injected with recombinant porcine GH exhibited no elevation in IRGH. It is speculated that exogenous GH inhibits the production of endogenous GH.
 ...
PMID:A radioimmunoassay for oncorhynchid growth hormone targeted to the physiological range. 788 79

Interest in the importance of the gut after injury or operation has waxed and waned over this century. Recent studies implicate the gut in septic complications and multiple organ failure after trauma, operations including cardiothoracic procedures, starvation, and other serious illnesses. Changes in the gut in sick patients include stress ulceration, bacterial overgrowth from stress ulceration prophylaxis, mucosal atrophy, loss of barrier function, increased permeability, and bacterial translocation. Such changes in relation to multiorgan failure are reviewed, along with methods to support the gut and prevent gastrointestinal failure. Preventive measures include stress ulceration prophylaxis, selective gut decontamination, enteral feeding, and adjuvants to promote gut function such as glutamine, fiber, and growth hormone. In cardiothoracic operations, the gut may be altered by the "whole body" inflammatory processes of cardiopulmonary bypass. Gastrointestinal complications after cardiothoracic operations are related primarily to low flow states. In 5,924 patients having cardiothoracic operations at St. Louis University Hospital from 1985 to 1991, multiorgan failure developed in 128 patients, with a mortality of 78%. Significant gastrointestinal problems occurred and contributed to multiorgan failure in a number of these patients. Support of the gastrointestinal tract and the prevention of multiorgan failure are important for the cardiothoracic surgeon.
 ...
PMID:The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. 827 17

The effect of 7 days of subcutaneously administered bovine growth hormone (bGH) (0.2 mg kg-1 day-1; n = 4) or an equivalent volume of 0.15 mol l-1 saline (n = 3) on protein metabolism was assessed in lambs. The catabolic response to 48 h of starvation and subsequent hypocaloric total parenteral nutrition (TPN) was measured using primed constant intravenous infusions of [15N]urea and [14C]leucine. Following 48 h of starvation and 7 h of TPN, bGH-treated animals had a significantly decreased rate of net protein catabolism compared with controls (mean(s.e.m.) 2.4(0.2) versus 3.2(0.3) g kg-1 day-1, P < 0.01). The mean(s.e.m.) rate of whole-body protein catabolism was also significantly decreased in bGH-treated animals at 10.9(0.3) g kg-1 day-1 compared with 12.9(0.7) g kg-1 day-1 in saline-treated controls (P < 0.05). In addition, the rates of net and whole-body protein catabolism decreased significantly (P < 0.05) during the period of hypocaloric parenteral feeding to mean(s.e.m.) values of 2.3(0.2) and 8.6(0.6) g kg-1 day-1 respectively in bGH-treated animals. By contrast, in saline-treated controls net and whole-body protein catabolism continued to increase during hypocaloric parenteral feeding. There was a significant decrease (P < 0.05) in the rate of [14C]leucine uptake in tissues of the gastrointestinal tract, heart and diaphragm in bGH-treated animals compared with controls. These results demonstrate that daily administration of growth hormone decreases the catabolic response to a metabolic stress, resulting in the conservation of protein in the heart, diaphragm, gastrointestinal tract and musculoskeletal system by a primary anticatabolic action. In addition, growth hormone therapy initiated before induction of the catabolic state enhances the protein-sparing effects of TPN. Further study is justified to determine whether growth hormone therapy initiated before elective or urgent surgery in the nutritionally depleted patient may have a role in reducing the severity of the postoperative catabolic state, particularly in the patient in whom a complicated course is anticipated.
 ...
PMID:Growth hormone therapy initiated before starvation ameliorates the catabolic state and enhances the protein-sparing effect of total parenteral nutrition. 833 Jan 62


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>